Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Myelination of the nervous system: mechanisms and functions.
Multiple sclerosis: summary of NICE guidance.
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Sexual dysfunction ın multiple sclerosis: Gender differences.
Age-dependent effects on the treatment response of natalizumab in MS patients.
Multiple sclerosis: Does aggressive MS warrant aggressive treatment?
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Oligodendrocytes Enforce Immune Tolerance of the Uninfected Brain by Purging the Peripheral Repertoire of Autoreactive CD8(+) T Cells.
Long-Term Results Underscore Value of Early MS Treatment
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Ginseng in the Treatment of Fatigue in Multiple Sclerosis: A Randomized Placebo-Controlled Double-Blind Pilot Study.
Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.
De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
MS related employment and disease modifying treatment in the German working population: 1994-2009.
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.

Pages